You just read:

Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at the American Thoracic Society 2017 International Conference

News provided by

Arena Pharmaceuticals, Inc.

May 16, 2017, 16:30 ET